发布时间:2018-04-30
浏览次数:745次
Host: University of Oxford (UOXF)
Objectives: To investigate the major differences in the pro-arrhythmic and anti-arrhythmic mechanisms underlying human whole-ventricular EP response to drugs in non-diseased versus diseased conditions. This project will build personalised models of human electro-physiology (in collaboration with F3 and F1), and simulate the activation of the heart to predict the safety and efficacy of pharmacological action in the individual subject. Special emphasis will be given to avoid arrhythmogenic effects, which currently have a huge interest for regulatory bodies (see letter of commitment by FDA). Results will be evaluated in collaboration with F14.
Planned secondment(s):
Industrial: JAN (P9, pharma industry). For 2M in Y2 to test the ideas in the company’s database of compounds.
Regulatory experience provided by interactions with the FDA (P4).
Clinical: co-supervision and interactions within cardiologists at the Oxford JRH (P7).
上一条:牛津大学心肌病博士
下一条:伦敦国王学院心脏研究博士
1、服务热线:欢迎致电好予服务热线:4000-551-509
2、在线咨询:欢迎点击这里进行网络在线咨询
3、在线留言:在线留言预约登记,我们会尽快安排资深的出国专家致电解答,为您提供最专业的出国咨询服务
1.本网独家发布的稿件和图片,未经本网允许,不得转载使用。获授权转载时务必注明来源。
2.本网转载其他媒体稿件是为了传播更多的信息,此类稿件不代表本网观点。如果本网转载的稿件涉及您的版权、名誉权等问题,请尽快与本网联系,本网将依照国家相关法律法规尽快删除。